News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
581,448 Results
Type
Article (19092)
Company Profile (166)
Press Release (562258)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (198416)
Career Advice (705)
Deals (30752)
Drug Delivery (89)
Drug Development (65653)
Employer Resources (54)
FDA (12405)
Job Trends (11100)
News (287895)
Policy (24146)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (820)
Accelerated approval (44)
ADA (26)
Adcomms (10)
Allergies (144)
Alliances (41815)
ALS (146)
Alzheimer's disease (1272)
Antibody-drug conjugate (ADC) (351)
Approvals (13038)
Artificial intelligence (512)
ASCO (219)
Autoimmune disease (251)
Automation (40)
Bankruptcy (319)
Best Places to Work (8368)
BIO (47)
Biologics (2)
BIOSECURE Act (10)
Biosimilars (192)
BioSpace Insights (77)
Biotechnology (102)
Bladder cancer (155)
Brain cancer (57)
Breast cancer (605)
Cancer (4497)
Cardiovascular disease (353)
Career advice (610)
Career pathing (15)
CAR-T (218)
CDC (8)
Celiac Disease (1)
Cell therapy (611)
Cervical cancer (41)
Clinical research (58891)
Collaboration (1734)
Commercialization (4)
Company closure (2)
Compensation (1497)
Complete response letters (61)
COVID-19 (1284)
CRISPR (82)
C-suite (1062)
Cystic fibrosis (126)
Data (6660)
Decentralized trials (1)
Denatured (23)
Depression (125)
Dermatology (69)
Diabetes (443)
Diagnostics (4833)
Digital health (46)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (271)
Drug pricing (126)
Drug shortages (15)
Duchenne muscular dystrophy (230)
Earnings (81419)
Editorial (25)
Employer branding (5)
Employer resources (50)
Events (99254)
Executive appointments (967)
FDA (15578)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (28)
Funding (1238)
Gene editing (164)
Generative AI (35)
Gene therapy (462)
GLP-1 (676)
Government (2011)
Grass and pollen (5)
Guidances (332)
Healthcare (11038)
Hematology (128)
HIV (55)
Huntington's disease (28)
IgA nephropathy (100)
Immunology and inflammation (168)
Immuno-oncology (76)
Indications (196)
Infectious disease (1516)
Inflammatory bowel disease (173)
Inflation Reduction Act (9)
Influenza (97)
Intellectual property (298)
Interviews (93)
IPO (13978)
IRA (33)
Job creations (3104)
Job search strategy (552)
JPM (29)
Kidney cancer (20)
Labor market (39)
Layoffs (254)
Leadership (11)
Legal (6580)
Licensing (9)
Liver cancer (55)
Longevity (24)
Lung cancer (640)
Lymphoma (344)
Machine learning (35)
Management (18)
Manufacturing (922)
Marketing (12)
MASH (164)
Medical affairs (1)
Medical device (9262)
Medtech (9416)
Mergers & acquisitions (17952)
Metabolic disorders (1068)
mRNA (110)
Multiple sclerosis (139)
NASH (15)
Neurodegenerative disease (299)
Neuropsychiatric disorders (72)
Neuroscience (2441)
Neurotech (1)
NextGen: Class of 2026 (3894)
Non-profit (1259)
Now hiring (24)
Obesity (427)
Opinion (158)
Ovarian cancer (175)
Pain (247)
Pancreatic cancer (227)
Parkinson's disease (278)
Partnered (21)
Patents (586)
Patient recruitment (601)
Peanut (39)
People (50706)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase 1 (18159)
Phase 2 (25893)
Phase 3 (19214)
Pipeline (8784)
Policy (165)
Postmarket research (2127)
Preclinical (7537)
Press Release (49)
Prostate cancer (236)
Psychedelics (31)
Radiopharmaceuticals (270)
Rare diseases (856)
Real estate (4460)
Recruiting (20)
Regulatory (19762)
Reports (28)
Research institute (957)
Resumes & cover letters (95)
Rett syndrome (42)
RNA editing (12)
RSV (53)
Schizophrenia (147)
Series A (226)
Series B (157)
Service/supplier (5)
Sickle cell disease (98)
Special edition (11)
Spinal muscular atrophy (113)
Sponsored (15)
Startups (2782)
State (2)
Stomach cancer (8)
Supply chain (95)
Tariffs (71)
The Weekly (53)
Vaccines (515)
Venture capital (56)
Weight loss (227)
Women's health (102)
Worklife (4)
Date
Today (12)
Last 7 days (281)
Last 30 days (1853)
Last 365 days (23053)
2026 (15035)
2025 (23303)
2024 (27247)
2023 (31380)
2022 (40750)
2021 (43343)
2020 (39856)
2019 (29704)
2018 (22626)
2017 (24681)
2016 (23525)
2015 (29422)
2014 (25671)
2013 (22077)
2012 (24096)
2011 (24440)
2010 (23672)
Location
Africa (467)
Alabama (81)
Alaska (2)
Arizona (336)
Arkansas (13)
Asia (30169)
Australia (4149)
California (12672)
Canada (3465)
China (1045)
Colorado (511)
Connecticut (465)
Delaware (274)
Europe (54684)
Florida (1934)
Georgia (409)
Hawaii (3)
Idaho (49)
Illinois (855)
India (99)
Indiana (554)
Iowa (16)
Japan (559)
Kansas (119)
Kentucky (36)
Louisiana (31)
Maine (28)
Maryland (1373)
Massachusetts (8691)
Michigan (324)
Minnesota (602)
Mississippi (5)
Missouri (106)
Montana (27)
Nebraska (16)
Nevada (118)
New Hampshire (68)
New Jersey (3190)
New Mexico (18)
New York (3113)
North Carolina (1525)
North Dakota (4)
Northern California (6350)
Ohio (303)
Oklahoma (17)
Oregon (29)
Pennsylvania (2407)
Puerto Rico (26)
Rhode Island (36)
South America (732)
South Carolina (79)
South Dakota (1)
Southern California (5221)
Tennessee (148)
Texas (2037)
United States (42908)
Utah (386)
Vermont (1)
Virginia (268)
Washington D.C. (51)
Washington State (987)
West Virginia (2)
Wisconsin (108)
Wyoming (2)
581,448 Results for "cumberland pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
July 1, 2026
·
3 min read
Press Releases
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses
April 23, 2026
·
3 min read
Business
Cumberland Pharmaceuticals to Announce First Quarter 2024 Financial Results
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, announced that it will release its first quarter 2024 financial results and provide a company update after the market closes on Tuesday, May 7, 2024.
April 30, 2024
·
2 min read
Business
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024.
May 7, 2024
·
21 min read
Business
Cumberland Pharmaceuticals to Announce Annual 2023 Financial Results
Cumberland Pharmaceuticals Inc., a specialty pharmaceuticals company, announced that it will release its annual 2023 financial results and provide a company update after the market closes on Tuesday, March 5, 2024.
February 27, 2024
·
2 min read
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $40 million in 2023 and provided $6 million in cash generated from operations.
March 5, 2024
·
24 min read
Press Releases
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
August 5, 2026
·
3 min read
Business
Cumberland Pharmaceuticals to Announce Third Quarter 2023 Financial Results
Cumberland Pharmaceuticals Inc., a specialty pharmaceuticals company, announced that it will release the third quarter 2023 financial results and provide a company update after the market closes on Tuesday, Nov. 7, 2023.
October 31, 2023
·
2 min read
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $10.1 million during the third quarter of 2023 and $30.2 million year to date.
November 7, 2023
·
24 min read
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
1 of 58,145
Next
